CALL - SPRINTER OPEN END - ROCHE GS Share Price

Certificat

SOROI

CH0206430057

Market Closed - Swiss Exchange 16:15:01 10/05/2024 BST
0.27 CHF +31.71% Intraday chart for CALL - SPRINTER OPEN END - ROCHE GS
Current month+50.00%
1 month+8.00%
Date Price Change Volume
10/05/24 0.27 +31.71% 15,000
08/05/24 0.205 +7.89% 2,000
07/05/24 0.19 +35.71% 15,000
06/05/24 0.14 +33.33% 0
03/05/24 0.105 +110.00% 0

Delayed Quote Swiss Exchange

Last update May 10, 2024 at 04:15 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
SOROI
ISINCH0206430057
Date issued 28/02/2013
Strike 212.7 CHF
Maturity Unlimited
Parity 50 : 1
Emission price 0.17 CHF
Emission volume N/A
Settlement Barausgleich
Currency CHF

Technical Indicators

Highest since issue 3.95 CHF
Lowest since issue 0.05 CHF
Spread 0.01 CHF
Spread %3.85%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
225.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.12%
Consensus
  1. Stock Market
  2. Certificates
  3. SOROI Certificat